Related Experiment Video

Updated: Jun 27, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Liver failure and the need for transplantation in three patients with hepatoportal sclerosis

B Geramizadeh1, S A Malek-Hosseini, H Salahi

  • 1Pathology Department, Transplant Research Center, Transplantation Ward, Shiraz University of Medical Sciences, Shiraz, Iran.

Transplantation Proceedings
|December 23, 2008
PubMed

Insights

Hepatoportal sclerosis (HPS) can cause noncirrhotic portal hypertension. This study highlights how small liver volume, fibrosis, and phlebosclerosis in HPS patients may lead to hepatic synthetic dysfunction.

Area of Science:

  • Hepatology
  • Pathology

Background:

  • Hepatoportal sclerosis (HPS) is a known cause of noncirrhotic portal hypertension.
  • Hepatic synthetic dysfunction is uncommon in HPS, but liver transplantation may be rarely required.

Observation:

  • This study examined the clinicopathologic features of 3 patients diagnosed with HPS via explanted liver analysis.
  • The patients presented with specific pathological characteristics.

Findings:

  • Small liver volume, significant portal fibrosis, and phlebosclerosis were identified as key features.
  • These features may contribute to the development of hepatic synthetic dysfunction in HPS.

Implications:

  • Understanding these clinicopathologic characteristics is crucial for managing HPS.
  • Further research may elucidate the mechanisms linking these findings to liver dysfunction and inform treatment strategies.

More Related Videos

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy05:20

Three-Dimensional Collagen Matrix Scaffold Implantation as a Liver Regeneration Strategy

Published on: June 29, 2021

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...